We are live on
!
Find out more
BNP Paribas Asset Management Portfolio holdings
AUM
$86.1B
1-Year Est. Return
29.11%
This Fund
S&P 500
This Quarter
Est. Return
-2.17%
1 Year Est. Return
+29.11%
3 Year Est. Return
+87.64%
5 Year Est. Return
+102.48%
10 Year Est. Return
+408.22%
AUM
$86.1B
AUM Growth
-$1.05B
(-1.2%)
Cap. Flow
+$4.86B
Cap. Flow
% of AUM
5.64%
Top 10 Holdings %
Top 10 Hldgs %
27.63%
Holding
2,366
New
101
Increased
1,396
Reduced
686
Closed
108
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$1.43B |
| 2 |
TotalEnergies
TTE
|
+$626M |
| 3 |
Deutsche Bank
DB
|
+$326M |
| 4 |
Stellantis
STLA
|
+$263M |
| 5 |
Broadcom
AVGO
|
+$237M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ciena
CIEN
|
+$291M |
| 2 |
Apple
AAPL
|
+$262M |
| 3 |
Amazon
AMZN
|
+$219M |
| 4 |
Tesla
TSLA
|
+$205M |
| 5 |
Meta Platforms (Facebook)
META
|
+$197M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 35.22% |
| 2 | Healthcare | 13.97% |
| 3 | Financials | 10.51% |
| 4 | Consumer Discretionary | 10.09% |
| 5 | Industrials | 8.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EFOR
1801
Everforth Inc
EFOR
$845M
| $32.2K | ﹤0.01% |
833
+206
| +33% | +$9.18K |
|
1802
Stepan Co
SCL
$1.31B
| $32.2K | ﹤0.01% |
645
+158
| +32% | +$8.46K |
|
1803
Green Brick Partners
GRBK
$3.13B
| $32.1K | ﹤0.01% |
498
+89
| +22% | +$6.26K |
|
1804
Alarm.com
ALRM
$2.56B
| $32K | ﹤0.01% |
742
+175
| +31% | +$8.35K |
|
1805
Phibro Animal Health
PAHC
$1.38B
| $32K | ﹤0.01% |
579
+146
| +34% | +$6.95K |
|
|
GRAL
1806
GRAIL Inc
GRAL
$2.91B
| $31.9K | ﹤0.01% |
618
+117
| +23% | +$9.06K |
|
1807
Magnite
MGNI
$2.65B
| $31.8K | ﹤0.01% |
+2,677
| New | +$35.9K |
|
1808
La-Z-Boy
LZB
$1.59B
| $31.6K | ﹤0.01% |
982
+334
| +52% | +$12.1K |
|
1809
OFG Bancorp
OFG
$2.21B
| $31.6K | ﹤0.01% |
780
-73,924
| -99% | -$2.99M |
|
1810
NuScale Power
SMR
$2.8B
| $31.4K | ﹤0.01% |
2,893
+989
| +52% | +$15K |
|
1811
Hanmi Financial
HAFC
$943M
| $31.2K | ﹤0.01% |
1,185
+441
| +59% | +$11.9K |
|
1812
Spectrum Brands
SPB
$2.04B
| $31.2K | ﹤0.01% |
423
+115
| +37% | +$8.19K |
|
|
PPLI
1813
People Inc
PPLI
$3.1B
| $31.1K | ﹤0.01% |
777
+60
| +8% | +$2.27K |
|
1814
Enovis
ENOV
$1.56B
| $31.1K | ﹤0.01% |
1,365
+403
| +42% | +$9.53K |
|
|
SEM
1815
DELISTED
Select Medical
SEM
| $30.8K | ﹤0.01% |
1,893
+376
| +25% | +$5.88K |
|
1816
Edgewise Therapeutics
EWTX
$4.39B
| $30.6K | ﹤0.01% |
972
+244
| +34% | +$7.04K |
|
1817
CTS Corp
CTS
$1.72B
| $30.6K | ﹤0.01% |
640
+208
| +48% | +$10.4K |
|
1818
Sonos
SONO
$1.75B
| $30.6K | ﹤0.01% |
2,281
+594
| +35% | +$8.97K |
|
1819
Newmark Group
NMRK
$2.73B
| $30.5K | ﹤0.01% |
2,035
+185
| +10% | +$2.92K |
|
1820
Tennant Co
TNC
$1.5B
| $30.4K | ﹤0.01% |
458
+159
| +53% | +$11.6K |
|
1821
Strategic Education
STRA
$1.71B
| $30.3K | ﹤0.01% |
365
+74
| +25% | +$6.03K |
|
1822
Arlo Technologies
ARLO
$1.4B
| $30.3K | ﹤0.01% |
2,126
+568
| +36% | +$7.59K |
|
1823
ICF International
ICFI
$1.44B
| $30.2K | ﹤0.01% |
463
-1,219
| -72% | -$99.1K |
|
1824
Protolabs
PRLB
$1.86B
| $30.2K | ﹤0.01% |
530
+118
| +29% | +$6.85K |
|
1825
CVR Energy
CVI
$3.36B
| $30.2K | ﹤0.01% |
897
+322
| +56% | +$8.28K |
|
Similar funds
BNP Paribas Asset Management's Q1 2026 Portfolio in Review
As of Q1 2026, BNP Paribas Asset Management held 2,366 positions worth $86.1B, down 1.2% from $87.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
BNP Paribas Asset Management deployed $4.86B of net new capital in Q1 2026, opening 101 new positions and adding to 1,396 existing holdings. Its largest new stake was Viking Holdings: 1,864,036 shares worth $137M.
By sector, the portfolio is most concentrated in Technology at 35% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Ciena, an estimated $291M trimmed.
- BNP Paribas Asset Management's largest Q1 2026 buy was Viking Holdings: 1,864,036 shares worth $137M.
- BNP Paribas Asset Management added most to AstraZeneca in Q1 2026, an estimated $1.43B increase.
- BNP Paribas Asset Management's biggest Q1 2026 reduction was Ciena, cutting an estimated $291M.
- BNP Paribas Asset Management fully exited Exact Sciences in Q1 2026, selling an estimated $35.9M.
- BNP Paribas Asset Management's ten largest holdings make up 28% of its $86.1B portfolio in Q1 2026.
- BNP Paribas Asset Management opened 101 new positions and closed 108 in Q1 2026.
- BNP Paribas Asset Management's portfolio value fell 1.2% quarter-over-quarter to $86.1B.
Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.